Orange Book product · Generic (ANDA)
ZILEUTON
ZILEUTON
Generic (ANDA)ANDA 204929TE ABRX RISING
At a glance
Mar 17, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 17, 2017
9 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ZILEUTON
Strength
600MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 204929
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of ZILEUTON
- 2007ZYFLO CRBrand (NDA)
NDA 022052 · CHIESI
- 1996ZYFLOBrand (NDA)
NDA 020471 · CHIESI
- 2022ZILEUTONGeneric (ANDA)
ANDA 215742 · ANNORA PHARMA
- 2022ZILEUTONGeneric (ANDA)
ANDA 211043 · TEVA PHARMS USA
- 2020ZILEUTONGeneric (ANDA)
ANDA 211390 · AIZANT
- 2019ZILEUTONGeneric (ANDA)
ANDA 212670 · STRIDES PHARMA INTL
- 2019ZILEUTONGeneric (ANDA)
ANDA 211972 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
